Triple-Negative Breast Cancers (TNBCs), a breast tumor type defined by lack ofestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER-2) accounts for about 10-15% of the total breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.